2-(3-cyanophenyl)-N-[(1S)-1-cyclopropylethyl]-4-methylimidazo[1,5-a]pyrimidine-8-carboxamide;2-(3-cyanophenyl)-N-(2-cyclopropylpropan-2-yl)-4-methylimidazo[1,5-a]pyrimidine-8-carboxamide;N-(2-cyclopropylpropan-2-yl)-2-(6-methoxy-2-pyridinyl)-4-methylimidazo[1,5-a]pyrimidine-8-carboxamide;N-(1-cyclopropyl-2,2,2-trifluoroethyl)-4-ethyl-2-(6-methoxy-2-pyridinyl)imidazo[1,5-a]pyrimidine-8-carboxamide;N-(1-cyclopropyl-2,2,2-trifluoroethyl)-2-(6-methoxy-2-pyridinyl)-4-methylimidazo[1,5-a]pyrimidine-8-carboxamide;2-(6-methoxy-2-pyridinyl)-4-methyl-N-(2-methylbut-3-yn-2-yl)imidazo[1,5-a]pyrimidine-8-carboxamide
C119H120F6N30O10 — CID 159927869
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-(3-cyanophenyl)-N-[(1S)-1-cyclopropylethyl]-4-methylimidazo[1,5-a]pyrimidine-8-carboxamide;2-(3-cyanophenyl)-N-(2-cyclopropylpropan-2-yl)-4-methylimidazo[1,5-a]pyrimidine-8-carboxamide;N-(2-cyclopropylpropan-2-yl)-2-(6-methoxy-2-pyridinyl)-4-methylimidazo[1,5-a]pyrimidine-8-carboxamide;N-(1-cyclopropyl-2,2,2-trifluoroethyl)-4-ethyl-2-(6-methoxy-2-pyridinyl)imidazo[1,5-a]pyrimidine-8-carboxamide;N-(1-cyclopropyl-2,2,2-trifluoroethyl)-2-(6-methoxy-2-pyridinyl)-4-methylimidazo[1,5-a]pyrimidine-8-carboxamide;2-(6-methoxy-2-pyridinyl)-4-methyl-N-(2-methylbut-3-yn-2-yl)imidazo[1,5-a]pyrimidine-8-carboxamide
2-(3-cyanophenyl)-N-[(1S)-1-cyclopropylethyl]-4-methylimidazo[1,5-a]pyrimidine-8-carboxamide;2-(3-cyanophenyl)-N-(2-cyclopropylpropan-2-yl)-4-methylimidazo[1,5-a]pyrimidine-8-carboxamide;N-(2-cyclopropylpropan-2-yl)-2-(6-methoxy-2-pyridinyl)-4-methylimidazo[1,5-a]pyrimidine-8-carboxamide;N-(1-cyclopropyl-2,2,2-trifluoroethyl)-4-ethyl-2-(6-methoxy-2-pyridinyl)imidazo[1,5-a]pyrimidine-8-carboxamide;N-(1-cyclopropyl-2,2,2-trifluoroethyl)-2-(6-methoxy-2-pyridinyl)-4-methylimidazo[1,5-a]pyrimidine-8-carboxamide;2-(6-methoxy-2-pyridinyl)-4-methyl-N-(2-methylbut-3-yn-2-yl)imidazo[1,5-a]pyrimidine-8-carboxamide (PubChem CID 159927869) has the molecular formula C119H120F6N30O10 and a molecular weight of 2244.46 g/mol. Its IUPAC name is 2-(3-cyanophenyl)-N-[(1S)-1-cyclopropylethyl]-4-methylimidazo[1,5-a]pyrimidine-8-carboxamide;2-(3-cyanophenyl)-N-(2-cyclopropylpropan-2-yl)-4-methylimidazo[1,5-a]pyrimidine-8-carboxamide;N-(2-cyclopropylpropan-2-yl)-2-(6-methoxy-2-pyridinyl)-4-methylimidazo[1,5-a]pyrimidine-8-carboxamide;N-(1-cyclopropyl-2,2,2-trifluoroethyl)-4-ethyl-2-(6-methoxy-2-pyridinyl)imidazo[1,5-a]pyrimidine-8-carboxamide;N-(1-cyclopropyl-2,2,2-trifluoroethyl)-2-(6-methoxy-2-pyridinyl)-4-methylimidazo[1,5-a]pyrimidine-8-carboxamide;2-(6-methoxy-2-pyridinyl)-4-methyl-N-(2-methylbut-3-yn-2-yl)imidazo[1,5-a]pyrimidine-8-carboxamide.
Molecular Properties
| Compound Name | 2-(3-cyanophenyl)-N-[(1S)-1-cyclopropylethyl]-4-methylimidazo[1,5-a]pyrimidine-8-carboxamide;2-(3-cyanophenyl)-N-(2-cyclopropylpropan-2-yl)-4-methylimidazo[1,5-a]pyrimidine-8-carboxamide;N-(2-cyclopropylpropan-2-yl)-2-(6-methoxy-2-pyridinyl)-4-methylimidazo[1,5-a]pyrimidine-8-carboxamide;N-(1-cyclopropyl-2,2,2-trifluoroethyl)-4-ethyl-2-(6-methoxy-2-pyridinyl)imidazo[1,5-a]pyrimidine-8-carboxamide;N-(1-cyclopropyl-2,2,2-trifluoroethyl)-2-(6-methoxy-2-pyridinyl)-4-methylimidazo[1,5-a]pyrimidine-8-carboxamide;2-(6-methoxy-2-pyridinyl)-4-methyl-N-(2-methylbut-3-yn-2-yl)imidazo[1,5-a]pyrimidine-8-carboxamide |
|---|---|
| PubChem CID | 159927869 |
| Molecular Formula | C119H120F6N30O10 |
| Molecular Weight | 2244.46 g/mol |
| Exact Mass | 2242.97 |
| IUPAC Name | 2-(3-cyanophenyl)-N-[(1S)-1-cyclopropylethyl]-4-methylimidazo[1,5-a]pyrimidine-8-carboxamide;2-(3-cyanophenyl)-N-(2-cyclopropylpropan-2-yl)-4-methylimidazo[1,5-a]pyrimidine-8-carboxamide;N-(2-cyclopropylpropan-2-yl)-2-(6-methoxy-2-pyridinyl)-4-methylimidazo[1,5-a]pyrimidine-8-carboxamide;N-(1-cyclopropyl-2,2,2-trifluoroethyl)-4-ethyl-2-(6-methoxy-2-pyridinyl)imidazo[1,5-a]pyrimidine-8-carboxamide;N-(1-cyclopropyl-2,2,2-trifluoroethyl)-2-(6-methoxy-2-pyridinyl)-4-methylimidazo[1,5-a]pyrimidine-8-carboxamide;2-(6-methoxy-2-pyridinyl)-4-methyl-N-(2-methylbut-3-yn-2-yl)imidazo[1,5-a]pyrimidine-8-carboxamide |
| SMILES | C#CC(C)(C)NC(=O)c1ncn2c(C)cc(-c3cccc(OC)n3)nc12.CCc1cc(-c2cccc(OC)n2)nc2c(C(=O)NC(C3CC3)C(F)(F)F)ncn12.COc1cccc(-c2cc(C)n3cnc(C(=O)NC(C)(C)C4CC4)c3n2)n1.COc1cccc(-c2cc(C)n3cnc(C(=O)NC(C4CC4)C(F)(F)F)c3n2)n1.Cc1cc(-c2cccc(C#N)c2)nc2c(C(=O)NC(C)(C)C3CC3)ncn12.Cc1cc(-c2cccc(C#N)c2)nc2c(C(=O)N[C@@H](C)C3CC3)ncn12 |
| InChI | InChI=1S/C21H21N5O.C20H20F3N5O2.C20H23N5O2.C20H19N5O.C19H18F3N5O2.C19H19N5O2/c1-13-9-17(15-6-4-5-14(10-15)11-22)24-19-18(23-12-26(13)19)20(27)25-21(2,3)16-7-8-16;1-3-12-9-14(13-5-4-6-15(25-13)30-2)26-18-16(24-10-28(12)18)19(29)27-17(11-7-8-11)20(21,22)23;1-12-10-15(14-6-5-7-16(22-14)27-4)23-18-17(21-11-25(12)18)19(26)24-20(2,3)13-8-9-13;1-12-8-17(16-5-3-4-14(9-16)10-21)24-19-18(22-11-25(12)19)20(26)23-13(2)15-6-7-15;1-10-8-13(12-4-3-5-14(24-12)29-2)25-17-15(23-9-27(10)17)18(28)26-16(11-6-7-11)19(20,21)22;1-6-19(3,4)23-18(25)16-17-22-14(10-12(2)24(17)11-20-16)13-8-7-9-15(21-13)26-5/h4-6,9-10,12,16H,7-8H2,1-3H3,(H,25,27);4-6,9-11,17H,3,7-8H2,1-2H3,(H,27,29);5-7,10-11,13H,8-9H2,1-4H3,(H,24,26);3-5,8-9,11,13,15H,6-7H2,1-2H3,(H,23,26);3-5,8-9,11,16H,6-7H2,1-2H3,(H,26,28);1,7-11H,2-5H3,(H,23,25)/t;;;13-;;/m...0../s1 |
| InChIKey | NZGHROHCKMSONM-YHMBDMJUSA-N |
| XLogP | 18.49 |
| TPSA | 491.80 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 34 |
| Rotatable Bonds | 28 |
| Heavy Atoms | 165 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2244.46 |
| LogP ≤ 5 | 18.49 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 34 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'triple_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159927869 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.